| The NovaLead pipeline includes multiple new pharmaceutical product opportunities, which are at various stages of development. The company expects that the time for its products to reach market would be 2 - 7 years, subject to satisfactory completion of clinical trials. It is expected that the clinical trialsfor the diabetic foot ulcer will begin in the first quarter of 2011. |
